Working Group 1
Data and methodology standardisation to develop and validate vocal biomarkers
Description
This WG will bring together clinicians (laryngologists, phoniatricians, voice quality experts, neurologists, cardiologists, pulmonologists, oncologists, psychiatrists…), academics (audio signal processing experts, AI experts), industry (including SMEs and start-ups focusing on a voice technology) and policy makers and regulators.
Objectives
- Improve reproducibility, robustness of vocal biomarkers
- Develop and validate standardised protocols for voice acquisition, voice feature extraction, audio processing pipeline, data analysis and model training
Working Group 2
Repository of open source data and software resources for vocal biomarkers
Description
This WG will be of particular interest for researchers and industry representatives involved in the design and development of vocal biomarkers.
Objectives
- Create and maintain a comprehensive repository of open source data and software resources.
Working Group 3
Ethical, data protection and privacy issues of vocal biomarkers
Description
This WG will bring together data privacy and security, ethics and legal experts to ensure the design and development of privacy-preserving vocal biomarkers.
Objectives
- Promote ethical and responsible practices in vocal biomarker research
- Ensure data ownership and privacy protection in voice-based data collection efforts and studies
- Facilitate collaboration and advancement in vocal biomarker research through data sharing and federated learning
Working Group 4
Translational research and go to market strategies
Description
This WG will bring together researchers and industry working in different aspects of voice-based solutions: applications (e.g. for diagnosing diseases, monitoring symptoms), integration with other technologies (e.g. video, wearable sensors, IoT…), health economics and business models.
Objectives
- Overcome go-to-market barriers
- Enhance understanding and compliance with EMA procedures, Act AI and 2017/745 (EU MDR) for the development of vocal biomarkers
Working Group 5
Dissemination
Description
This WG will involve all stakeholders, and will be a crucial point to increase the impact of eVoiceNet.
Objectives
- Gain end users’ trust
- Reach policymakers, service providers, public and market